Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Heart Failure × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 NET 1 Endocrine 1 Breast 1

Conditions

Neuroendocrine Tumors 49 Thyroid Neoplasms 17 Adrenocortical Carcinoma 17 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 16 Thyroid Cancer, Papillary 15 Neoplasms 15 Multiple Endocrine Neoplasia Type 1 15 Melanoma 15 Breast Neoplasms 15 Thyroid Carcinoma, Anaplastic 14 Small Cell Lung Carcinoma 13 Colorectal Neoplasms 13 Carcinoma, Medullary 13 Prostatic Neoplasms 12 Carcinoma, Hepatocellular 12 Carcinoma, Neuroendocrine 11 Adenocarcinoma, Follicular 11 Uterine Cervical Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Salivary Gland Neoplasms 10 Pheochromocytoma 10 Pancreatic Neoplasms 10 Insulinoma 10 Colonic Neoplasms 10 Carcinoid Tumor 10 Pituitary Neoplasms 9 Neoplasm Metastasis 9 Lung Neoplasms 9 Head and Neck Neoplasms 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730417 2012-11-21

mIBG

Duke University

Phase 1 Completed

Heart Failure, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡